Fluvastatin: Efficacy and safety in reducing cardiac events
10.1517/14656566.6.11.1883
Saved in:
Main Authors: | Chan, M.Y., Lee, C.H. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/133067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferX
by: Lecca, P., et al.
Published: (2014) -
Clinical Drug Development - Practical Issues in Clinical Pharmacology Studies
by: Wise, S.D.
Published: (2014) -
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
by: Yong, W.P., et al.
Published: (2014) -
Optimizing dihydroartemisinin-piperaquine dose regimens in a paediatric population: a pharmacokinetic-pharmacodynamic approach using monte-carlo simulations
by: Palang Chotsiri, et al.
Published: (2015) -
Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Carbapenems in Critically Ill Patients
by: Apinya Boonpeng
Published: (2022)